Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis-Burkina Faso, 2014-2015.

Kambiré D, Soeters HM, Ouédraogo-Traoré R, Medah I, Sangaré L, Yaméogo I, Sawadogo G, Ouédraogo AS, Ouangraoua S, McGee L, Srinivasan V, Aké F, Congo-Ouédraogo M, Ky Ba A, Whitney CG, Novak RT, Van Beneden C; MenAfriNet Consortium.

J Infect. 2018 Mar;76(3):270-279. doi: 10.1016/j.jinf.2017.12.002. Epub 2017 Dec 15.

2.

Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.

Diallo AO, Soeters HM, Yameogo I, Sawadogo G, Aké F, Lingani C, Wang X, Bita A, Fall A, Sangaré L, Ouédraogo-Traoré R, Medah I, Bicaba B, Novak RT; MenAfriNet Consortium.

PLoS One. 2017 Nov 2;12(11):e0187466. doi: 10.1371/journal.pone.0187466. eCollection 2017.

3.

Effect of a vaccine to prevent serogroup A N meningitidis epidemics in Africa.

Meyer SA, Novak RT.

Lancet Infect Dis. 2017 Aug;17(8):789-790. doi: 10.1016/S1473-3099(17)30300-6. Epub 2017 May 22. No abstract available.

4.

The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012.

Retchless AC, Hu F, Ouédraogo AS, Diarra S, Knipe K, Sheth M, Rowe LA, Sangaré L, Ky Ba A, Ouangraoua S, Batra D, Novak RT, Ouédraogo Traoré R, Wang X.

mSphere. 2016 Nov 16;1(6). pii: e00201-16. eCollection 2016 Nov-Dec.

5.

Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013.

Kambiré D, Soeters HM, Ouédraogo-Traoré R, Medah I, Sangare L, Yaméogo I, Sawadogo G, Ouédraogo AS, Hema-Ouangraoua S, McGee L, Srinivasan V, Aké F, Congo-Ouédraogo M, Sanou S, Ba AK, Novak RT, Van Beneden C; MenAfriNet Consortium.

PLoS One. 2016 Nov 10;11(11):e0166384. doi: 10.1371/journal.pone.0166384. eCollection 2016.

6.

Whole-Genome Characterization of Epidemic Neisseria meningitidis Serogroup C and Resurgence of Serogroup W, Niger, 2015.

Kretz CB, Retchless AC, Sidikou F, Issaka B, Ousmane S, Schwartz S, Tate AH, Pana A, Njanpop-Lafourcade BM, Nzeyimana I, Nse RO, Deghmane AE, Hong E, Brynildsrud OB, Novak RT, Meyer SA, Oukem-Boyer OOM, Ronveaux O, Caugant DA, Taha MK, Wang X; Niger Response Team.

Emerg Infect Dis. 2016 Oct;22(10):1762-1768. doi: 10.3201/eid2210.160468.

7.

Public Health Impact After the Introduction of PsA-TT: The First 4 Years.

Diomandé FV, Djingarey MH, Daugla DM, Novak RT, Kristiansen PA, Collard JM, Gamougam K, Kandolo D, Mbakuliyemo N, Mayer L, Stuart J, Clark T, Tevi-Benissan C, Perea WA, Preziosi MP, Marc LaForce F, Caugant D, Messonnier N, Walker O, Greenwood B.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S467-72. doi: 10.1093/cid/civ499.

8.

Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010-2014.

Djingarey MH, Diomandé FV, Barry R, Kandolo D, Shirehwa F, Lingani C, Novak RT, Tevi-Benissan C, Perea W, Preziosi MP, LaForce FM.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S434-41. doi: 10.1093/cid/civ551. Review.

9.

Neisseria meningitidis serogroup W, Burkina Faso, 2012.

MacNeil JR, Medah I, Koussoubé D, Novak RT, Cohn AC, Diomandé FV, Yelbeogo D, Kambou JL, Tarbangdo TF, Ouédraogo-Traoré R, Sangaré L, Hatcher C, Vuong J, Mayer LW, Djingarey MH, Clark TA, Messonnier NE.

Emerg Infect Dis. 2014 Mar;20(3):394-9. doi: 10.3201/eid2003.131407.

10.

Population-based surveillance for bacterial meningitis in China, September 2006-December 2009.

Li Y, Yin Z, Shao Z, Li M, Liang X, Sandhu HS, Hadler SC, Li J, Sun Y, Li J, Zou W, Lin M, Zuo S, Mayer LW, Novak RT, Zhu B, Xu L, Luo H; Acute Meningitis and Encephalitis Syndrome Study Group.

Emerg Infect Dis. 2014 Jan;20(1):61-9. doi: 10.3201/eid2001.120375.

11.

Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012.

Drobeniuc J, Greene-Montfort T, Le NT, Mixson-Hayden TR, Ganova-Raeva L, Dong C, Novak RT, Sharapov UM, Tohme RA, Teshale E, Kamili S, Teo CG.

Emerg Infect Dis. 2013 Feb;19(2):218-22; quiz 353. doi: 10.3201/eid1902.120961.

12.

Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.

Novak RT, Kambou JL, Diomandé FV, Tarbangdo TF, Ouédraogo-Traoré R, Sangaré L, Lingani C, Martin SW, Hatcher C, Mayer LW, Laforce FM, Avokey F, Djingarey MH, Messonnier NE, Tiendrébéogo SR, Clark TA.

Lancet Infect Dis. 2012 Oct;12(10):757-64. doi: 10.1016/S1473-3099(12)70168-8. Epub 2012 Jul 18.

13.

Hepatitis C virus transmission in hemodialysis units: importance of infection control practices and aseptic technique.

Thompson ND, Novak RT, Datta D, Cotter S, Arduino MJ, Patel PR, Williams IT, Bialek SR.

Infect Control Hosp Epidemiol. 2009 Sep;30(9):900-3. doi: 10.1086/605472.

PMID:
19642900
14.

Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America.

Wu HM, Harcourt BH, Hatcher CP, Wei SC, Novak RT, Wang X, Juni BA, Glennen A, Boxrud DJ, Rainbow J, Schmink S, Mair RD, Theodore MJ, Sander MA, Miller TK, Kruger K, Cohn AC, Clark TA, Messonnier NE, Mayer LW, Lynfield R.

N Engl J Med. 2009 Feb 26;360(9):886-92. doi: 10.1056/NEJMoa0806414.

15.

Genetic diversity of clinical isolates of Bacillus cereus using multilocus sequence typing.

Hoffmaster AR, Novak RT, Marston CK, Gee JE, Helsel L, Pruckler JM, Wilkins PP.

BMC Microbiol. 2008 Nov 6;8:191. doi: 10.1186/1471-2180-8-191.

16.

Recovery of a Burkholderia thailandensis-like isolate from an Australian water source.

Gee JE, Glass MB, Novak RT, Gal D, Mayo MJ, Steigerwalt AG, Wilkins PP, Currie BJ.

BMC Microbiol. 2008 Apr 2;8:54. doi: 10.1186/1471-2180-8-54.

17.

Clinical evaluation of a type III secretion system real-time PCR assay for diagnosing melioidosis.

Meumann EM, Novak RT, Gal D, Kaestli ME, Mayo M, Hanson JP, Spencer E, Glass MB, Gee JE, Wilkins PP, Currie BJ.

J Clin Microbiol. 2006 Aug;44(8):3028-30.

18.

Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei.

Novak RT, Glass MB, Gee JE, Gal D, Mayo MJ, Currie BJ, Wilkins PP.

J Clin Microbiol. 2006 Jan;44(1):85-90.

19.

Use of 16S rRNA gene sequencing for rapid confirmatory identification of Brucella isolates.

Gee JE, De BK, Levett PN, Whitney AM, Novak RT, Popovic T.

J Clin Microbiol. 2004 Aug;42(8):3649-54.

20.

Phototrophic utilization of taurine by the purple nonsulfur bacteria Rhodopseudomonas palustris and Rhodobacter sphaeroides.

Novak RT, Gritzer RF, Leadbetter ER, Godchaux W.

Microbiology. 2004 Jun;150(Pt 6):1881-91.

PMID:
15184574
21.

The hemodynamic effect of profound hypercapnia on acute hypoxic respiratory failure.

Slotman GJ, Machiedo GW, Novak RT, Rush BF Jr.

Circ Shock. 1983;11(3):187-94.

PMID:
6652877
22.

Alteration of postischemic renal pathology by prostaglandin infusion.

Casey KF, Machiedo GW, Lyons MJ, Slotman GJ, Novak RT.

J Surg Res. 1980 Jul;29(1):1-10. No abstract available.

PMID:
6999241
23.

The hemodynamic effects of prostaglandin E1 (PGE1) in acute hypoxic respiratory failure.

Slotman GJ, Machiedo GW, Casey KF, Novak RT, Rush BF Jr.

Adv Shock Res. 1980;3:283-9.

PMID:
7197870

Supplemental Content

Loading ...
Support Center